Prosecution Insights
Last updated: August 18, 2026

Examiner: ABUZEINEH, HANAN ISAM

Tech Center 1700 • Art Units: 1600 1633 1651 1732

This examiner grants 56% of resolved cases

Performance Statistics

56.0%
Allow Rate
-9.0% vs TC avg
104
Total Applications
+51.4%
Interview Lift
1457
Avg Prosecution Days
Based on 75 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
17.4%
§102 Novelty
46.0%
§103 Obviousness
27.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18692616 In Vitro Cell Co-Cultures of Neuronal Cells, Astrocytes, and Oligodendrocytes Non-Final OA KATHOLIEKE UNIVERSITEIT LEUVEN
17997575 MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORS Final Rejection The Regents of the University of Colorado, A Body Corporate
18559778 SYNTHETIC RECEPTORS Non-Final OA UCL BUSINESS LTD
18001372 COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE Non-Final OA HANGZHOU LEADING EDGE PHARMACEUTICAL LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month